Management of patients with endocrine ophthalmopathy and Graves' disease: results of an endocrinologist and ophthalmologist survey in Russia
https://doi.org/10.21518/2079-701X-2015-7-44-47
Abstract
Endocrine ophthalmopathy is a chronic autoimmune disease of the orbit which can cause loss of vision. It is a multidisciplinary problem involving specialists from different areas. The aim of the study was to compare management of patients with endocrine ophthalmopathy by endocrinologists vs. ophthalmologists. Material and methods: questionnare for doctors. The survey results demonstrated that practical diagnosis and treatment of ophtalmopathy are different from the current guidelines, and multi-disciplinary teams should be created to determine the best tactics for the management of patient with Graves' disease and endocrine ophthalmopathy.
About the Authors
Н. Мартиросян
Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
Russian Federation
Russian Federation
Н. Петунина
Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
Russian Federation
Russian Federation
Л. Трухина
Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России
Russian Federation
Russian Federation
С. Саакян
Московский научно-исследовательский институт глазных болезней им. Гельмгольца Минздрава России
Russian Federation
Russian Federation
О. Пантелеева
Московский научно-исследовательский институт глазных болезней им. Гельмгольца Минздрава России
Russian Federation
Russian Federation
References
1. Lindholm J, Laurberg P. Hyperthyroidism, exophthalmos, and goiter: historical notes on the orbitopathy. Thyroid. 2010 Mar; 20(3): 291-300.
2. Петунина Н.А., Трухина Л.В., Мартиросян Н.С. Эндокринная офтальмопатия: современный взгляд. Проблемы эндокринологии, 6, 2012, 24-32.
3. Wiersinga WM, Kahaly GJ (eds): Graves' Orbitopathy: A Multidisciplinary Approach -Questions and Answers. Basel, Karger, 2010.
4. Дедов И.И., Мельниченко ГА., Свириденко Н.Ю. [и др.]. Федеральные клинические рекомендации по диагностике и лечению эндокринной офтальмопатии при аутоиммунной патологии щитовидной железы. Проблемы Эндокринологии 2015; 61(1): 61-74.
5. Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S, Heckmann C, Esser J, Morgenthaler NG. Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab. 2006 Sep; 91(9): 3464-70.
6. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthal-mopathy. Clin Endocrinol (Oxf) 2000; 52: 267-71.
7. Свириденко Н.Ю., Лихванцева В.Г., Беловалова И.М., Шеремета М.С., Табеева К.И. Антитела к рецептору ТТГ как предикторы тяжести и исходов эндокринной офтальмопатии у пациентов с болезнью Грейвса. Пробл. эндокринол. 2011. 2. 23-26.
8. Bartalena L, Baldeschi L, Dickinson A, Eckstein A et al. European Group on Graves' Orbitopathy (EUGOGO). Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. 2008 Mar; 158(3): 273-85.
9. Kahaly GJ, Pitz S, Hommel G & Dittmar M. Rand omized, single-blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopa-thy. Journal of Clinical Endocrinology and Metabolism 2005; 90: 5234-5240.
10. Kauppinen-Makelin R, Karmi A, Leinonen E, Loyttyniemi E, Salonen O, Sane T, Setala K, Viik ari J, Heufelder A & Valimaki M. High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmologica Scandinavica 2002; 80: 316-321.
11. Lai A, Sassi L, Compri E, Marino F, et al. Lower dose prednisone prevents radioiodine-associat-ed exacerbation of initially mild or absent Grave's orbitopathy: a retrospective cohort study. J Clin Endocrinol Metab 2010; 95(3): 1333-7.
12. Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA. 1993 Jan 27; 269(4): 479-82.
13. Thornton J, Kelly SP, Harrison RA & Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye 2006; 20: 1-11.
14. Bartalena L, Tanda ML, Piantanida E, Lai A, Pinchera A. Relationship between management of hyperthyroidism and course of the ophthalmopathy. J Endocrinol Invest. 2004; 27(3): 288-94.
Review
For citations:
, , , , . Management of patients with endocrine ophthalmopathy and Graves' disease: results of an endocrinologist and ophthalmologist survey in Russia. Meditsinskiy sovet = Medical Council. 2015;(7):44-47. (In Russ.) https://doi.org/10.21518/2079-701X-2015-7-44-47
Views:
396
Email this article 